Related Experiment Video
Updated: Oct 23, 2025
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.4K
Management of cardiogenic shock
Holger Thiele1, Suzanne de Waha-Thiele, Anne Freund
1Heart Center Leipzig at University of Leipzig, Leipzig, Germany.
Summary
Cardiogenic shock management, especially after heart attack, still has high mortality. This review focuses on evidence-based treatments, prioritizing randomized trials over expert opinion for better patient outcomes.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) remains a critical complication of acute myocardial infarction (AMI) with persistently high short-term mortality rates (40-50%).
- Despite increased research, the evidence base for CS management is limited, with many treatment decisions relying on expert consensus rather than robust randomized controlled trials (RCTs).
Purpose of the Study:
- To provide an updated review of cardiogenic shock management, primarily in the context of acute myocardial infarction.
- To highlight state-of-the-art treatments supported by RCTs or robust comparative studies.
Main Methods:
- Review of current literature focusing on randomized clinical trials and matched comparisons.
- Analysis of evidence for key interventions in cardiogenic shock management.
Main Results:
- Early revascularization is the only definitively proven intervention for AMI-related CS.
- Intra-aortic balloon pumping shows limited effectiveness.
- Most management strategies lack strong evidence from RCTs.
Conclusions:
- There is a critical need for more high-quality research, particularly RCTs, to guide cardiogenic shock management.
- Clinical practice should prioritize evidence-based interventions, moving beyond expert consensus where possible.
Related Concept Videos
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
135
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
135
01:30Heart Failure V: Medical Management
53
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
53
01:29Cardiomyopathy V: Interprofessional Care
71
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
71
01:28Acute Coronary Syndrome IV: Interprofessional Care
57
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
57
01:24Blood Pressure Imbalances and Circulatory Shock
1.1K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.1K
01:30Cardiomyopathy II: Dilated Cardiomyopathy
85
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
85